In a significant shift for Louisiana’s political landscape and the composition of the U.S. Senate’s healthcare leadership, Senator Bill Cassidy will not seek re-election after failing … Read more
Bristol Myers Squibb (BMS) has entered into a massive strategic collaboration with China’s Hengrui Pharma, a deal that underscores a growing trend of Western pharmaceutical giants … Read more
The Centers for Medicare and Medicaid Services (CMS) is proposing to roll back breakthrough device payment flexibilities, a move that could significantly alter how hospitals are … Read more
The landscape of modern medicine is currently caught between two opposing forces: a rigorous regulatory push to uncover hidden data from the past and a high-speed … Read more
For decades, clinicians have joked about patients arriving at appointments with a “diagnosis” found via a quick Google search. But the era of “Dr. Google” has … Read more
Congress is returning from a two-week recess to a legislative calendar dominated by a high-stakes health care agenda. At the center of the debate is the … Read more
The biotechnology sector is currently navigating a period of strategic realignment, characterized by a high volume of executive movement as companies pivot from early-stage research to … Read more
The Food and Drug Administration has once again denied approval for an experimental treatment for advanced skin cancer developed by Replimune Group, marking a second setback … Read more
A coalition of Senate Democrats is moving to prioritize a comprehensive overhaul of the American health care system, focusing heavily on the persistent issue of rising … Read more
Steve Ubl, the long-time leader of the Pharmaceutical Research and Manufacturers of America, is stepping down as CEO of the industry’s most influential trade group. Ubl, … Read more
As generative artificial intelligence continues to permeate the healthcare sector, a growing number of U.S. States are moving to establish guardrails around the utilize of AI-driven … Read more
The precarious nature of biotech innovation was laid bare this month as Kezar Life Sciences, a little firm developing treatments for rare diseases, began the process … Read more